Your browser doesn't support javascript.
loading
Bispecific antibody platforms for cancer immunotherapy.
Lameris, Roeland; de Bruin, Renée C G; Schneiders, Famke L; van Bergen en Henegouwen, Paul M P; Verheul, Henk M W; de Gruijl, Tanja D; van der Vliet, Hans J.
Affiliation
  • Lameris R; Department of Medical Oncology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
  • de Bruin RC; Department of Medical Oncology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
  • Schneiders FL; Department of Medical Oncology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
  • van Bergen en Henegouwen PM; Division of Cell Biology, Department of Biology, Faculty of Science, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands.
  • Verheul HM; Department of Medical Oncology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
  • de Gruijl TD; Department of Medical Oncology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
  • van der Vliet HJ; Department of Medical Oncology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Electronic address: jj.vandervliet@vumc.nl.
Crit Rev Oncol Hematol ; 92(3): 153-65, 2014 Dec.
Article in En | MEDLINE | ID: mdl-25195094
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antibodies, Bispecific / Neoplasms / Antineoplastic Agents Language: En Journal: Crit Rev Oncol Hematol Year: 2014 Type: Article Affiliation country: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antibodies, Bispecific / Neoplasms / Antineoplastic Agents Language: En Journal: Crit Rev Oncol Hematol Year: 2014 Type: Article Affiliation country: Netherlands